These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6152833)
21. [Prevention and treatment of motion sickness]. Marks E; Swiecicki W Wiad Lek; 1974 Jan; 27(1):37-42. PubMed ID: 4152152 [No Abstract] [Full Text] [Related]
22. Drug therapy. Anticholinergics. Greenblatt DJ; Shader RI N Engl J Med; 1973 Jun; 288(23):1215-9. PubMed ID: 4144756 [No Abstract] [Full Text] [Related]
23. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy. Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of meclizine hydrochloride in prevention of seasickness. LOOMIS GR Mil Med; 1955 Jul; 117(1):51-3. PubMed ID: 14393609 [No Abstract] [Full Text] [Related]
26. Promethazine as a motion sickness treatment: impact on human performance and mood states. Cowings PS; Toscano WB; DeRoshia C; Miller NE Aviat Space Environ Med; 2000 Oct; 71(10):1013-22. PubMed ID: 11051308 [TBL] [Abstract][Full Text] [Related]
27. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations. Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260 [TBL] [Abstract][Full Text] [Related]
29. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea. Noy S; Shapira S; Zilbiger A; Ribak J Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687 [TBL] [Abstract][Full Text] [Related]
30. [Antihistaminics and motion sickness]. GUNS P; GILLAIN A; DOYEN E Ann Otolaryngol; 1953; 70(8-9):496-502. PubMed ID: 13125081 [No Abstract] [Full Text] [Related]
31. [Antihistamine-amphetamine therapy of motion sickness]. ARNER O; DIAMANT H Sven Lakartidn; 1954 Oct; 51(41):2580-5. PubMed ID: 13216603 [No Abstract] [Full Text] [Related]
32. Neural mechanisms of motion sickness. Takeda N; Morita M; Horii A; Nishiike S; Kitahara T; Uno A J Med Invest; 2001 Feb; 48(1-2):44-59. PubMed ID: 11286016 [TBL] [Abstract][Full Text] [Related]
33. Effects of scopolamine on autonomic profiles underlying motion sickness susceptibility. Uijtdehaage SH; Stern RM; Koch KL Aviat Space Environ Med; 1993 Jan; 64(1):1-8. PubMed ID: 8424733 [TBL] [Abstract][Full Text] [Related]
34. [Pathogenesis and therapy of seasickness]. GLASER EM Dtsch Med Wochenschr; 1953 Mar; 78(12):392-3. PubMed ID: 13067879 [No Abstract] [Full Text] [Related]
35. Effect of drugs on motion sickness produced by short exposures to artificial waves. GLASER EM; McCANCE RA Lancet; 1959 Apr; 1(7078):853-6. PubMed ID: 13655604 [No Abstract] [Full Text] [Related]
37. The prevention of motion sickness in orbital flight. Graybiel A Life Sci Space Res; 1976; 14():109-18. PubMed ID: 11977268 [TBL] [Abstract][Full Text] [Related]
38. Antihistamines in sea sickness. ARNER O; DIAMANT H; GOLDBERG L; WRANGE G Arch Int Pharmacodyn Ther; 1958; 117(3-4):404-18. PubMed ID: 13606948 [No Abstract] [Full Text] [Related]
39. Motion sickness. Noel P; Norris C J La State Med Soc; 1996 Jan; 148(1):7-11. PubMed ID: 8576633 [TBL] [Abstract][Full Text] [Related]
40. Statement on motion sickness. Committee to Advise on Tropical Medicine and Travel Can Commun Dis Rep; 2003 Nov; 29():1-12. PubMed ID: 14655530 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]